Hematopoiesis

Ravi Kumar Gutti, PhD, is Professor in the Department of Biochemistry of the School of Life Sciences at the University of Hyderabad, India. He has extensive research and teaching experience from Harvard Medical School (USA), National Institutes of Health (USA), Moffitt Cancer and Research Centre (USA), and RWTH Aachen (Germany). His research primarily focuses on understanding the molecular mechanisms in low platelet diseases and is well funded by several grants from the Government of India and other organizations. He has received awards and recognition from several prominent national and international organizations, including a Chancellor's Award from the University of Hyderabad for making significant contributions to teaching and research. Dr. Gutti has authored several publications in reputed international journals and has presented his research at international scientific meetings.

• 1. Unrevealing the Mechanism of Zebrafish Hematopoiesis: A Novel Approach 2. Investigative Tools to Study Blood Cells: Focus on Single Cell Isolation and Analysis 3. Evaluation of Chitosan and Its Derivatives in Immunomodulating Blood Sentinel Cells 4. Proteoglycans and Glycosaminoglycans Regulating Functions of the Hematopoietic Stem Cell Niche 5. Epigenetics of Hematopoiesis: Role of HATs and HDACs 6. Systems Biology Approaches Toward Understanding Human Long Non-Coding RNA Hematopoietic Cells 7. Clinical Outcomes of Defective Hematopoiesis 8. Circulating Messengers of Blood and Their Clinical Applications 9. Hematopoiesis and Cancer Stem Cells: The Seed and the Soil Crosstalk 10. lncRNAs in Types of Leukaemia 11. Minimal Residual Disease (MRD) as a Prognostic Factor in Acute Myeloid Leukaemia

"Provid[es] an accurate overview of the functional importance of hematopoiesis from different perspectives and the surrounding molecular mechanisms that influence the process of hematopoiesis in one way or another. Extremely pertinent and up-to-date information . . . Highly recommended . . . Sheds light on different factors that indulge and regulate the hematopoietic events. The uniqueness of this book encompasses the myriad of information on the biology of normal and aberrant hematopoiesis, epigenetic factors, and on the research tools to assist in the deeper study of aspects relating to the status of blood cells in cancerous scenario. . . . Some specifics of leukemia/lymphoma governed by various non-conventional molecules are also part of this book."—From the Foreword by Prof. Dr. Natália Cruz-Martins, PhD, Cooperativa de Ensino Superior Politécnico e Universitário (CESPU); Faculdade de Medicina, Universidade do Porto (FMUP), Porto, Portugal